Dear Editors,Pemphigus vulgaris (PV) is a rare intraepidermal autoimmune bullous dermatosis mainly caused by anti-desmoglein (Dsg)3 with/without anti-Dsg1 autoantibodies. 1 This letter reports three specific PV patients with refractory oral lesions who tested negative for anti-Dsg antibodies and whose skin lesions regressed completely after immunosuppressant treatment. All refractory oral lesions in the three patients were positive for Herpes simplex virus (HSV) and healed only after anti-virus treatment.Three patients with multiple erosions and flaccid blisters on scalp, trunk, and oral mucosa (patient 3 with concomitant vulvar erosions) were diagnosed with PV by the presence of anti-Dsg autoantibodies, histopathology, and direct immunofluorescence examinations. Upon confirmation of the diagnosis, systemic immunosuppressants were prescribed to treat the disease. Patient 1 was initially treated with prednisone (40 mg/day) and ciclosporin (75 mg, thrice a day); patients 2 and 3 were initially treated with methylprednisolone(60 mg/day) and azathioprine (50 mg, twice a day), and the azathioprine was replaced by mycophenolate mofetil (1,000 mg, twice a day) in patient 2 due to a decrease in white blood cells three weeks later. Patients 2 and 3 were also treated with intravenous immunoglobulins (0.4 g/kg⋅body weight [BW]/d*5d) once during the disease. In all three patients, with the addition of immunosuppressants, all the lesions on scalp and trunk (vulva in patient 3), as well as part of the lesions on oral mucosa gradually healed and the titer of anti-Dsg autoantibodies dropped to negative (Table 1). However, part of the oral lesions remained and were resistant to therapy in the three patients (Figures 1a, b, 2a, b). Additionally, some new oral lesions appeared in patient 1. The remaining oral lesions in patients 1 and 2 were topically injected with triamcinolone acetonide but showed no improvement, with some